Insight Molecular Diagnostics Inc. Gross Profit
Insight Molecular Diagnostics Inc. (IMDX) reported Gross Profit of $157.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement
us-gaap:GrossProfit · last filed 2026-08-10
- Insight Molecular Diagnostics Inc. gross profit for the quarter ending 2026-06-30 was $157.00K, a 53.55% decline year-over-year.
- Insight Molecular Diagnostics Inc. gross profit for the quarter ending 2026-03-31 was $15.00K, a 98.87% decline year-over-year.
- Insight Molecular Diagnostics Inc. gross profit for the quarter ending 2025-12-31 was $496.00K, a 16.64% decline year-over-year.
- Insight Molecular Diagnostics Inc. gross profit for the quarter ending 2025-09-30 was $139.00K, a 178.00% increase year-over-year.
- Insight Molecular Diagnostics Inc. gross profit for fiscal 2025 was $2.30M, a 210.54% increase from fiscal 2024.
- Insight Molecular Diagnostics Inc. gross profit for fiscal 2024 was $740.00K, a 79.18% increase from fiscal 2023.
- Insight Molecular Diagnostics Inc. gross profit for fiscal 2023 was $413.00K.
- Insight Molecular Diagnostics Inc. gross profit for fiscal 2022 was -$18.00K, a 101.27% decline from fiscal 2021.
| Period end | Gross Profit 3 month | Gross Profit 3 month as first filed | Gross Profit 6 month | Gross Profit 6 month as first filed | Gross Profit 9 month | Gross Profit 9 month as first filed | Gross Profit 12 month | Gross Profit 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $157.00K 10-Q · filed 2026-08-10 | $172.00K 10-Q · filed 2026-08-10 | $668.00K derived: sum of 3 quarters · filed 2026-08-10 | $807.00K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | $15.00K 10-Q · filed 2026-05-13 | $511.00K derived: sum of 2 quarters · filed 2026-05-13 | $650.00K derived: sum of 3 quarters · filed 2026-05-13 | $988.00K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | $496.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $635.00K derived: sum of 2 quarters · filed 2026-03-26 | $973.00K derived: sum of 3 quarters · filed 2026-08-10 | $2.30M 10-K · filed 2026-03-26 | ||||
| 2025-09-30 | $139.00K 10-Q · filed 2025-11-10 | $477.00K derived: sum of 2 quarters · filed 2026-08-10 | $1.80M 10-Q · filed 2025-11-10 | $2.40M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | $338.00K 10-Q · filed 2026-08-10 | $350.00K 10-Q · filed 2025-08-11 | $1.66M 10-Q · filed 2026-08-10 | $1.68M 10-Q · filed 2025-08-11 | $2.26M derived: sum of 3 quarters · filed 2026-08-10 | $2.31M derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-03-31 | $1.32M 10-Q · filed 2026-05-13 | $1.92M derived: sum of 2 quarters · filed 2026-05-13 | $1.97M derived: sum of 3 quarters · filed 2026-05-13 | $2.02M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $595.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $645.00K derived: sum of 2 quarters · filed 2026-03-26 | $695.00K derived: sum of 3 quarters · filed 2026-03-26 | $740.00K 10-K · filed 2026-03-26 | ||||
| 2024-09-30 | $50.00K 10-Q · filed 2025-11-10 | $100.00K derived: sum of 2 quarters · filed 2025-11-10 | $145.00K 10-Q · filed 2025-11-10 | $28.00K derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | $50.00K 10-Q · filed 2025-08-11 | $95.00K 10-Q · filed 2025-08-11 | -$22.00K derived: sum of 3 quarters · filed 2025-08-11 | $226.00K derived: sum of 4 quarters · filed 2025-08-11 | ||||
| 2024-03-31 | $45.00K 10-Q · filed 2025-05-12 | -$98.00K 10-Q · filed 2024-05-15 | -$72.00K derived: sum of 2 quarters · filed 2025-05-12 | $176.00K derived: sum of 3 quarters · filed 2025-05-12 | $448.00K derived: sum of 4 quarters · filed 2025-05-12 | |||
| 2023-12-31 | -$117.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $131.00K derived: sum of 2 quarters · filed 2025-03-24 | $403.00K derived: sum of 3 quarters · filed 2025-03-24 | $413.00K 10-K · filed 2025-03-24 | ||||
| 2023-09-30 | $248.00K 10-Q · filed 2024-11-12 | $520.00K derived: sum of 2 quarters · filed 2024-11-12 | $530.00K 10-Q · filed 2024-11-12 | $503.00K derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $272.00K 10-Q · filed 2024-08-08 | $282.00K 10-Q · filed 2024-08-08 | $255.00K derived: sum of 3 quarters · filed 2024-08-08 | -$14.00K derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $10.00K 10-Q · filed 2024-05-15 | -$17.00K derived: sum of 2 quarters · filed 2024-05-15 | -$286.00K derived: sum of 3 quarters · filed 2024-05-15 | -$255.00K derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | -$27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | -$296.00K derived: sum of 2 quarters · filed 2024-04-16 | -$265.00K derived: sum of 3 quarters · filed 2024-04-16 | -$18.00K 10-K · filed 2024-04-16 | ||||
| 2022-09-30 | -$269.00K 10-Q · filed 2023-11-09 | -$1.17M 10-Q · filed 2022-11-10 | -$238.00K derived: sum of 2 quarters · filed 2023-11-09 | $9.00K 10-Q · filed 2023-11-09 | -$2.02M 10-Q · filed 2022-11-10 | $2.61M derived: sum of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | $31.00K 10-Q · filed 2023-08-10 | -$314.00K 10-Q · filed 2022-08-12 | $278.00K 10-Q · filed 2023-08-10 | -$847.00K 10-Q · filed 2022-08-12 | $2.88M derived: sum of 3 quarters · filed 2023-08-10 | $2.01M derived: sum of 4 quarters · filed 2023-08-10 | ||
| 2022-03-31 | $247.00K 10-Q · filed 2023-05-15 | -$533.00K 10-Q · filed 2022-05-12 | $2.85M derived: sum of 2 quarters · filed 2023-05-15 | $1.98M derived: sum of 3 quarters · filed 2023-05-15 | $1.59M derived: sum of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-12 | $1.74M derived: sum of 2 quarters · filed 2023-04-12 | $1.34M derived: sum of 3 quarters · filed 2023-04-12 | $1.42M 10-K · filed 2023-04-12 | $188.00K 10-K · filed 2022-03-11 | |||
| 2021-09-30 | -$866.00K 10-Q · filed 2022-11-10 | -$1.26M derived: sum of 2 quarters · filed 2022-11-10 | -$1.18M 10-Q · filed 2022-11-10 | -$1.39M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | -$394.00K 10-Q · filed 2022-08-12 | -$315.00K 10-Q · filed 2022-08-12 | -$528.00K derived: sum of 3 quarters · filed 2022-08-12 | -$574.00K derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | $79.00K 10-Q · filed 2022-05-12 | -$134.00K derived: sum of 2 quarters · filed 2022-05-12 | -$180.00K derived: sum of 3 quarters · filed 2022-05-12 | -$402.00K derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | -$213.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | -$259.00K derived: sum of 2 quarters · filed 2022-03-11 | -$481.00K derived: sum of 3 quarters · filed 2022-03-11 | -$639.00K 10-K · filed 2022-03-11 | ||||
| 2020-09-30 | -$46.00K 10-Q · filed 2021-11-09 | -$268.00K derived: sum of 2 quarters · filed 2021-11-09 | -$426.00K 10-Q · filed 2021-11-09 | |||||
| 2020-06-30 | -$222.00K 10-Q · filed 2021-08-11 | -$380.00K 10-Q · filed 2021-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |